Marshall Wace Funds LP - MW TOPS Emerging Markets (US) Fund

Marshall Wace's absence from prior EDGAR filings combined with five named GPs (Bennett, Flaherty, Healy, Mulvey alongside the entity itself) signals either a new emerging markets strategy spinout from a larger multi-strategy platform or a first-time hedge fund filing by a team previously operating under a parent entity's exemption, which affects operational independence and key-person risk.

A mid-2026 emerging markets hedge fund filing exploits the post-2024 rotation into EM equity and currency volatility; filing under 506(b) no-public-solicitation signals reliance on an established LP network rather than broad placement, implying this manager has prior institutional relationships but is new to independent fundraising in this strategy.

Verify whether any of the five named GPs hold key-man provisions that tie redemption gates or management continuity to individual departures, and confirm whether Marshall Wace Ltd. (the entity GP) is the operating vehicle or a shell—the absence of prior EDGAR history makes it critical to establish the actual organizational structure and whether this team has managed emerging markets allocations previously under a different vehicle.